NKG2D CAR-T cells lysed NKG2DL-expressing GBM cells and GSCs in vitro and eliminated xenograft tumors of the U251 and U87 cell lines in vivo, without significant treatment-related toxicity. The gene discussed is KLRK1; the disease is glioblastoma.